Cargando…
Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease
SIMPLE SUMMARY: Liver metastases secondary to neuroendocrine tumors (NETs) are common at the time of diagnosis and are associated with worse quality of life and overall survival. This review focuses on the biomarkers and genetics associated with NETs, with a particular focus on disease diagnosis, pr...
Autores principales: | Alexander, Erica S., Ziv, Etay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137277/ https://www.ncbi.nlm.nih.gov/pubmed/37190177 http://dx.doi.org/10.3390/cancers15082249 |
Ejemplares similares
-
Hepatic Hilar Block as an Adjunct to Transarterial Embolization of Neuroendocrine Tumors: A Retrospective Review of Safety and Efficacy
por: Jain, Samagra, et al.
Publicado: (2023) -
Neuroendocrine Tumors: A Focus on Liver Metastatic Lesions
por: Limouris, Georgios S.
Publicado: (2012) -
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
por: Wong, Hui-li, et al.
Publicado: (2018) -
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
por: Siebenhüner, Alexander R., et al.
Publicado: (2022) -
Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
por: Gossing, Wilhelm, et al.
Publicado: (2020)